Alahist D Tablet
Product Images NDC 50991-776

2 FDA label images from Poly Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Alahist D (NDC 50991-776). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Poly Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Insert (Alahistdback)

Insert (Alahistdback)
Drug Facts label panel for Alahist D Tablets, containing pheniramine maleate 17.5 mg and phenylephrine hydrochloride 10 mg per tablet. The label includes active ingredients, uses, warnings, directions for adults and children, other information, inactive ingredients, and manufacturer details for Poly Pharmaceuticals, Inc. It provides guidance on dosage, contraindications, and precautions for use.*
FDA Label Image

Label (Alahistd)

Label (Alahistd)
The packaging label for Alahist D Tablets by Poly Pharmaceuticals, Inc. It is an oral human OTC drug featuring Pheniramine Maleate 17.5 mg and Phenylephrine Hydrochloride 10 mg as active ingredients. The label states 100 tablets per package and highlights the product as an antihistamine and nasal decongestant.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.